مرکز اطلاعات علمی Scientific Information Database (SID) - Trusted Source for Research and Academic Resources

video

مرکز اطلاعات علمی Scientific Information Database (SID) - Trusted Source for Research and Academic Resources

sound

مرکز اطلاعات علمی Scientific Information Database (SID) - Trusted Source for Research and Academic Resources

Persian Version

مرکز اطلاعات علمی Scientific Information Database (SID) - Trusted Source for Research and Academic Resources

View:

294
مرکز اطلاعات علمی Scientific Information Database (SID) - Trusted Source for Research and Academic Resources

Download:

105
مرکز اطلاعات علمی Scientific Information Database (SID) - Trusted Source for Research and Academic Resources

Cites:

Information Journal Paper

Title

ORAL OMEPRAZOLE IN PATIENTS UNDERGOING COMBINATION ENDOSCOPIC THERAPY FOR BLEEDING PEPTIC ULCERS: A PROSPECTIVE DOUBLE-BLIND RANDOMIZED STUDY

Pages

  172-177

Abstract

 Background: Endoscopic therapies can decrease the morbidity of patients with high risk peptic ulcer. The aim of this study was to evaluate the beneficial effects of oral OMEPRAZOLE therapy in patients with bleeding peptic ulcer who received combined endoscopic treatment (epinephrine injection and ARGON PLASMA COAGULATION).Materials and Methods: Eighty six patients with bleeding from gastric, duodenal or stomal ulcers and endoscopic stigmata of recent bleeding were enrolled in our study. All patients received injection of epinephrine (1:10,000) and also their ulcers were treated with Argon Plasma Coagulator. The patients then randomly assigned to receive oral OMEPRAZOLE (40 mg every 12 hours) or placebo.Results: Five (11.6%) of 43 patients in the placebo group had rebleeding; but no rebleeding was detected among 43 patients in OMEPRAZOLE group (p= 0.05). One patient in the Placebo group underwent surgery for control of his rebleeding; but none of the patients in OMEPRAZOLE group needed surgery. One patient in the placebo group and none of the patients in the OMEPRAZOLE group died. The average hospital stay was 5 days in the OMEPRAZOLE group and 5.8 days in the placebo group.Conclusions: Addition of oral OMEPRAZOLE to combined ENDOSCOPIC THERAPY significantly reduces recurrent bleeding rates.

Cites

  • No record.
  • References

  • No record.
  • Cite

    APA: Copy

    ANSARI, R., TABIB, S.M., ALI ASGARI, A., MOHAMMADNEZHAD, M., MIRNASERI, S.M.M., MIKAEILI, J., ZAMANI, F., FAKHAR, R., KHATIBIAN, M., KHALEGHI, S., & MALEKZADEH, R.. (2005). ORAL OMEPRAZOLE IN PATIENTS UNDERGOING COMBINATION ENDOSCOPIC THERAPY FOR BLEEDING PEPTIC ULCERS: A PROSPECTIVE DOUBLE-BLIND RANDOMIZED STUDY. GOVARESH JOURNAL, 10(3 (SN 52)), 172-177. SID. https://sid.ir/paper/532305/en

    Vancouver: Copy

    ANSARI R., TABIB S.M., ALI ASGARI A., MOHAMMADNEZHAD M., MIRNASERI S.M.M., MIKAEILI J., ZAMANI F., FAKHAR R., KHATIBIAN M., KHALEGHI S., MALEKZADEH R.. ORAL OMEPRAZOLE IN PATIENTS UNDERGOING COMBINATION ENDOSCOPIC THERAPY FOR BLEEDING PEPTIC ULCERS: A PROSPECTIVE DOUBLE-BLIND RANDOMIZED STUDY. GOVARESH JOURNAL[Internet]. 2005;10(3 (SN 52)):172-177. Available from: https://sid.ir/paper/532305/en

    IEEE: Copy

    R. ANSARI, S.M. TABIB, A. ALI ASGARI, M. MOHAMMADNEZHAD, S.M.M. MIRNASERI, J. MIKAEILI, F. ZAMANI, R. FAKHAR, M. KHATIBIAN, S. KHALEGHI, and R. MALEKZADEH, “ORAL OMEPRAZOLE IN PATIENTS UNDERGOING COMBINATION ENDOSCOPIC THERAPY FOR BLEEDING PEPTIC ULCERS: A PROSPECTIVE DOUBLE-BLIND RANDOMIZED STUDY,” GOVARESH JOURNAL, vol. 10, no. 3 (SN 52), pp. 172–177, 2005, [Online]. Available: https://sid.ir/paper/532305/en

    Related Journal Papers

  • No record.
  • Related Seminar Papers

  • No record.
  • Related Plans

  • No record.
  • Recommended Workshops






    Move to top
    telegram sharing button
    whatsapp sharing button
    linkedin sharing button
    twitter sharing button
    email sharing button
    email sharing button
    email sharing button
    sharethis sharing button